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Abstract: Superficial spreading early gastric cancer (EGC) is a rare
disease that is treated mainly by surgery. There are few studies on the
safety of endoscopic treatment for patients with superficial spreading
EGC. The aims of this study were to (1) investigate the risk of lymph
node metastasis of superficial spreading EGC and (2) investigate the
potential criteria for endoscopic treatment of superficial spreading EGC
using surgical specimens.
Between 2000 and 2010, patients who received curative surgery of
R0 resection at Severance Hospital (Seoul, Korea) for early gastric
cancer were enrolled. The superficial spreading EGC was defined as
cancer in which the longest tumor length was 6 cm. The medical
records of the patients were reviewed retrospectively.
Of the 3813 patients with EGC, 140 (3.7%) had lesions  6 cm,
whereas 3673 (96.3%) had lesions< 6 cm. Patients with superficial
spreading EGC had higher rates of submucosal cancer (59.3% vs
45.7%, P¼ 0.002), lymphovascular invasion (18.6% vs 9.8%,
P< 0.001), and lymph node metastasis (15.7% vs 10.1%, P¼ 0.033)
compared with patients with common EGC (< 6 cm). Multivariate
analysis revealed that a tumor  6 cm was not strongly associated with
lymph node metastasis in EGC, as compared with a tumor< 6 cm, but
submucosal invasion and lymphovascular invasion were strongly
associated with lymph node metastasis in EGC. In mucosal cancere, MD, PhD, Hee , PhD,
e, MD, PhD
Superficial spreading EGCwas not associated with an increased risk
of lymph node metastasis compared with common EGC. We suggest
that differentiated intramucosal superficial spreading EGC without
ulceration can be treated by endoscopic submucosal dissection.
(Medicine 95(14):e3242)
Abbreviations: EGC = early gastric cancer, EMR = endoscopic
mucosal resection, ESD = endoscopic submucosal dissection, QOL
= quality of life.
INTRODUCTION
G astric cancer is the third leading cause of cancer death inKorea.1,2 The detection of early gastric cancer (EGC) has
been aided by increased upper endoscopy screening and the
development of endoscopic technology. The mortality from
gastric cancer has therefore decreased due to early detection,
that is, increased diagnosis in the early stages.3,4
Gastrectomy with lymph node dissection is a standard
treatment for EGC, and the presence of lymph node metastasis
is an important prognostic factor for patient outcomes. Cur-
rently, endoscopic mucosal resection (EMR) or endoscopic
submucosal dissection (ESD) is performed for endoscopic
resection of EGC without evidence of lymph node metasta-
sis.5–7 The expanded criteria provided by Gotoda et al have
been applied to endoscopic treatment of early gastric cancer.8 If
the tumor is confined to the mucosa, lacks ulcers, and has
differentiated histology, the success of endoscopic resection is
independent of tumor size.8
Occasionally, a large but superficially deep gastric
cancer is encountered. This type of gastric cancer was
first mentioned in 1949 by Golden and Stout, who described
it as a ‘‘superficial spreading carcinoma’’ characterized by
wide and superficial extension with a limited depth of vertical
invasion.9 Since then, this type of gastric cancer has been
reported in many studies.10,11 Recently, superficial spreading
EGC has become a focus of endoscopic treatment. Although
surgical resection is considered the standard treatment for
superficial spreading EGC, endoscopic treatment has been
attempted for EGC of any size that meets the criteria outlined
by Gotoda et al in limited conditions. However, few studies
have investigated the safety of endoscopic treatment of super-
ficial spreading EGC with respect to the risk of lymph node
metastasis. In this study, we aimed to investigate the rate of
lymph nodemetastasis of superficial spreading EGC to identify
endoscopic and pathologic features of patients without lympher to help develop criteria for the safe
for this type of cancer using surgical
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metastasis. Results are expressed as odds ratios (OR) and 95%METHODS
Patients
All patients who received radical gastrectomy in Severance
Hospital, Yonsei University College of Medicine (Seoul, Korea),
were enrolled in this study. The operation method for inclusion
was radical subtotal gastrectomy or total gastrectomy with D2
lymph node dissection.12 The paraffin-embedded surgical speci-
mens from gastrectomywere sliced at 2-mm intervals. Generally,
special immunohistochemical staining was not performed to
discover submucosal invasion or lymphovascular invasion. The
pathology reports of tumor diameter, histology, depth of invasion,
lymphovascular invasion, and lymph node metastasis were
reviewed.According to the criteria of the JapaneseGastricCancer
Association,13 patients with 4 types of pathology were included:
well-differentiated adenocarcinoma, moderately differentiated
adenocarcinoma, poorly differentiated carcinoma, and signet ring
cell carcinoma. The exclusion criteria were a history of previous
gastrectomy or endoscopic treatment and R1 and R2 resections.
This study was approved by the Institutional Review Board for
Human Research of Yonsei University College of Medicine. The
need for informed consent was waived because the data were
anonymized before analysis.
Definition
Superficial spreadingEGCwasdefined asEGCwith a tumor
>60mm in diameter, in accordance with established Japanese
cancer criteria (Figure 1).14 The diameter wasmeasured from the
resected specimen after operation and the longest diameter of the
tumor was used. The differentiated and undifferentiated types
were defined according to the criteria outlined by the Japanese
Gastric Cancer Association.13 The differentiated type included
well differentiated and moderately differentiated adenocarcino-
mas, whereas the undifferentiated type included poorly differ-
entiated and signet ring cell carcinomas.
Lee et alStatistical Analysis
Statistical analysis was performed using SPSS software,
version 12.0 (SPSS Inc., Chicago, IL). Categorical variables
FIGURE 1. Superficial spreading early gastric cancer. On the
greater curvature of themid-body, large spreading nodular lesions
were found after indigocarmine dye spray.
2 | www.md-journal.comwere compared using the chi-square test and continuous vari-
ables in 2 groups were compared using Student’s t-test. Logistic
regression analysis was used to evaluate the risk of lymph node
Medicine  Volume 95, Number 14, April 2016confidence intervals (CI). P values< 0.05 were considered
significant for all statistical analyses.
RESULTS
A total of 3989 patients with EGC underwent gastrectomy
with lymph node dissection between March 2000 and February
2010. Of these, 176 were excluded due to previous treatment
(n¼ 129) and unclassified pathology (n¼ 47). Of the remaining
3813 patients, 140 (3.67%, 76 men and 64 women) were
classified as superficial spreading EGC (Figure 2).
The rate of superficial spreading EGC was significantly
higher than that of common EGC (<6 cm) in women (45.7% vs
34.6%, P¼ 0.007) (Table 1). Age, tumor location, and presence
of ulcers were not significantly different between these 2 groups.
The superficial spreading EGC group had a higher rate of
undifferentiated cancer compared with the common EGC group
(<6 cm); however, this trend was not significant (P¼ 0.178).
Submucosal invasion (59.3% vs 45.7%, P¼ 0.002), lympho-
vascular invasion (18.6% vs 9.8%, P< 0.001), and lymph node
metastasis (15.7% vs 10.1%, P¼ 0.033) were all significantly
higher in the superficial spreading EGC group compared with
the common EGC group (< 6 cm).
The rate of total gastrectomy was higher in the superficial
spreading EGC group than in the common EGC group (<6 cm)
(21.4% vs 12.7%, P¼ 0.012) (Table 2). Moreover, the total
numbers of dissected lymph nodes were higher in the superficial
spreading EGC group than in the common EGC group (<6 cm)
(P¼ 0.019). However, the total number of metastatic lymph
nodes was not different between the superficial spreading EGC
and the common EGC group (P¼ 0.491).
Univariate analysis revealed that lymph node metastasis
was strongly associated with superficial spreading EGC (OR:
1.65, 95% CI, 1.03–2.64; P¼ 0.035) (Table 3). However,
multivariable analysis revealed that lymph node metastasis
was not associated with superficial spreading EGC (OR:
1.33, 95% CI: 0.82–2.15; P¼ 0.253). Undifferentiated cancer
type, submucosal invasion, and lymphovascular invasion were
all strongly associated with an increased risk of lymph node
metastasis. For patients with mucosal cancers without ulcers,
the rate of lymph node metastasis of superficial spreading EGC
(7.7%) was higher than that of common EGC (<6 cm,
5.3%;< 3 cm, 4.9%; and< 2 cm, 5.3%). However, these differ-
ences were not significant (P¼ 0.458, 0.358, and 0.455,
respectively) (Table 4).The clinicopathologic features of the 4 cases of superficial
spreading EGCwith mucosal invasion and no ulcers are listed in
Table 5. All cases had undifferentiated cancer.
DISCUSSION
The multivariable analysis performed in this study
revealed that superficial spreading EGC was not associated
with an increased risk of lymph node metastasis. However,
univariate analysis showed that the rate of lymph node metas-
tasis was higher for tumors 6 cm than for tumors< 6 cm.
These findings suggest that histological characteristics, depth
of invasion, and lymphovascular invasion are more strongly
associated with lymph node metastasis than tumor size in
superficial spreading EGC.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
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FIGURE 2. Flowchart of patient enrollment.EGC has not yet been established, tumors with a longest
diameter>60mm and with limited invasion depth are generally
defined as superficial spreading type in Japan and Korea.15
TABLE 1. Clinicopathological Characteristics of the Superficially
Variable 6 cm (n¼ 140)
Sex (men:women) 76 (54.3%):64 (45.7%
Age, years (meanSD) 55.2 11.9
Location
Upper third 11 (7.9%)
Middle third 50 (35.7%)
Lower third 79 (56.4%)
Ulcerative lesion
Presence 19 (13.6%)
Tumor diameter, mm (meanSD) 71.9 16.8
Histology
Well differentiated 24 (17.1%)
Moderately differentiated 36 (25.7%)
Poorly differentiated 38 (27.1%)
Signet ring cell 42 (30%)
Depth of invasion
Intramucosal 57 (40.7%)
Submucosal 83 (59.3%)
Lymphovascular invasion 26 (18.6%)
Lymph node metastasis 22 (15.7%)
Nominal variables were analyzed by the chi-square test; continuous vari
SD¼ standard deviation.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.Although superficial spreading is typical of this type of EGC,
the pathophysiology of this feature has not been elucidated.
Similarly, the mechanism by which the invasion depth is limited
has not been identified. The rate of superficial spreading EGC is
Spreading and Common Types of Early Gastric Cancer
Tumor Size
<6 cm (n¼ 3673) P Value
) 2403 (65.4%):1270 (34.6%) 0.007
56.8 11.5 0.101
0.186
353 (9.6%)
1053 (28.7%)
2267 (61.7%)
0.975
492 (13.5%)
22.4 11.9 <0.001
0.178
829 (22.6%)
1086 (29.6%)
813 (22.1%)
945 (25.7%)
0.002
1996 (54.3%)
1677 (45.7%)
361 (9.8%) <0.001
371 (10.1%) 0.033
ables were analyzed by Student’s t-test.
www.md-journal.com | 3
TABLE 2. Comparison of Operation-Related Findings Between the Superficially Spreading and Common Types of Early Gastric
Cancer
Tumor Size
Variable 6 cm (n¼ 140) <6 cm (n¼ 3673) P Value
Approach 0.104
Open 126 (90%) 3123 (85%)
Laparoscopy 14 (10%) 550 (15%)
Gastrectomy type 0.012
Total gastrectomy 30 (21.4%) 469 (12.7%)
Subtotal gastrectomy 110 (78.6%) 3204 (87.3%)
Operation time, min (mean SD) 153.6 48.9 155.9 50.6 0.619
Dissected lymph nodes (meanSD) 38.6 14.6 35.6 13.7 0.019
Metastatic lymph nodes (meanSD) 0.36 1.02 0.28 1.26 0.491
Nominal variables were analyzed by the chi-square test; continuous variables were analyzed by Student’s t-test.
Lee et al Medicine  Volume 95, Number 14, April 2016low, 6.5% to 11.0% of all EGC cases,15–18 whereas the
incidence of lymph node metastasis in superficial spreading
EGC ranges from 18% to 30%.15,16,18 In our study, superficial
spreading EGC accounted for 3.7% of all EGC cases, with a
lymph node metastasis rate of 15.7%. The overall prognoses of
the superficial spreading and common types of EGC appear to
be similar. Kim et al reported that the superficial spreading and
common types of EGC did not exhibit significant differences in
their overall 5-year and 10-year survival rates.19
Although lymph node metastasis was more prevalent in the
superficial spreading EGC group compared with the common
SD¼ standard deviation.EGC group, the incidence was within the range reported in
previous studies.20–22 A few studies have reported that super-
ficial spreading EGC (but not common EGC) is significantly
TABLE 3. Risk Factors of Lymph Node Metastasis in Early Gastric
Univariate Analysis
Variable Odds Ratio (95% CI)
Age (>60) 1.06 (0.86–1.31)
Sex (male) 1.07 (0.86–1.34)
Location
Upper third 1
Middle third 1.89 (1.18–3.03)
Lower third 1.86 (1.18–2.92)
Ulcerative lesion 1.6 (1.22–2.1)
Tumor size
<6 cm 1
6 cm 1.65 (1.03–2.64)
Histology
Differentiated 1
Undifferentiated 1.16 (0.94–1.42)
Depth of invasion
Mucosal 1
Submucosal 3.55 (2.81–4.48)
Lymphovascular invasion 1.65 (1.23–2.23)
CI¼ confidence interval
4 | www.md-journal.comassociated with lymph node metastasis; however, these studies
did not adjust for confounding variables.16,18
Although the tumor behavior of superficial spreading
EGC is not well established, some studies have indicated that
these tumors may display milder biological behavior than
common EGC.23,24 For example, reduced expression levels
of epidermal growth factor and transforming growth factor-ß
were observed in superficial spreading EGC compared with
common EGC; moreover, apoptosis was higher in superficial
spreading EGC than in common EGC.23,24 In addition,
lower DNA ploidy patterns were seen in superficial spreading
EGC.25 This evidence might explain the lack of association
between superficial spreading EGC and lymph node meta-
stasis. However, further studies of tumor behavior and
Cancer With Curative Resection (n¼3813)
Multivariate Analysis
P Value Odds Ratio (95% CI) P Value
0.548 1.04 (0.83–1.29) 0.741
0.493 0.89 (0.71–1.12) 0.318
1
0.008 2.07 (1.29–3.35) 0.003
0.007 2.16 (1.37–3.41) 0.001
0.001 1.32 (0.99–1.75) 0.053
1
0.035 1.33 (0.82–2.15) 0.253
1
0.164 1.31 (1.04–1.65) 0.021
1
<0.001 3.59 (2.83–4.56) <0.001
0.001 1.53 (1.12–2.08) 0.007
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
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Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.investigations on the molecular level are needed to fully test
this hypothesis.
In this study, we sought to investigate the characteristics of
patients with superficial spreading EGC and no lymph node
metastasis. In these patients, endoscopic treatment could be
applied carefully. As subtotal gastrectomy and total gastrect-
omy with D2 lymph node dissection are relatively invasive
procedures, the risk of adverse postoperative events is a serious
concern. Moreover, the quality of life (QOL) is typically
affected during the first 3 months after curative surgery, with
20% to 35% of all patients continuing to suffer from functional
or symptomatic problems.26–28 Endoscopic treatments such as
EMR and ESD are widely used. The QOL after endoscopic
treatment is superior to that after surgery, because recovery is
relatively fast and the preserved stomach functions properly.
Due to these advantages, the indications of ESD have recently
been expanded. However, Kim et al reported that careful
consideration is needed before endoscopic resection is applied
to superficial spreading EGC, due to the higher risk of sub-
mucosal invasion and lymph node metastasis.19 Our study is
consistent with the study by Kim et al in that submucosal
invasion and lymph node metastasis were more prevalent in
superficial spreading EGC than in common EGC. We sought to
identify the circumstances in which lymph node metastasis is
absent, as these conditions are ideal for ESD. To this end, we
compared the clinicopathological findings of patients with
intramucosal superficial spreading EGC, intramucosal EGC
<6 cm, and intramucosal EGC <2 cm without ulceration.
Although undifferentiated histology was more common in
intramucosal superficial spreading EGC without ulceration,
lymph node metastasis was not significantly different between
intramucosal superficial spreading EGC and intramucosal com-
mon EGC without ulceration. Subgroup analysis of intramu-
cosal superficial spreading EGC identified 4 patients with
lymph node metastasis and undifferentiated pathology. There-
fore, we suggest that ESD is a potential alternative method for
treating differentiated intramucosal superficial spreading EGC
without ulceration.
The major strength of our study was the large number of
patients with superficial spreading EGC, which allowed for
robust analysis, in contrast to previous studies. Moreover, this
may be the first study to investigate the conditions under which
ESD is considered to be a safe treatment modality. However,
this study also had some limitations. First, this study was
retrospective in nature and only examined surgically resected
cases. Second, all subjects were enrolled at a single tertiary
institution, which may have introduced a selection bias. For
example, our rates of undifferentiated type EGC were high, as
compared with Kim et al’s study (47.8% vs 38%).19 This might
have been caused by endoscopic treatment in cases of small and
differentiated EGC in practice. We attempted to exclude this
bias by using a multivariable regression test. In addition, D2
lymph node dissection was considered a standard procedure for
lymph node dissection during the enrollment period for
patients.13,18 D1 dissection is recommended in differentiated
small tumors with T1a and cT1bN0. This point should be
carefully interpreted.12,29
In conclusion, superficial spreading EGC was not associ-
ated with an increased risk of lymph node metastasis. In cases of
mucosal cancer with differentiated pathology and no ulceration,
superficial spreading EGC was not accompanied by any lymph
Superficial Spreading Early Gastric Cancernode metastasis. These findings suggest that ESD is a suitable
option for a limited number of patients with superficial spread-
ing EGC. Further large-scale prospective studies should be
www.md-journal.com | 5
TABLE 5. Characteristics of Patients With Lymph Node Metastasis in Superficial Spreading Mucosal Cancer Without Ulceration
(n¼4)
No. Sex Age Location Tumor size Ulcerative Lesion LND LNM Histology LVI
1 Female 40 Antrum 60 mm () 21 1 Signet ring cell ()
2 Female 59 Antrum 60 mm () 43 1 Poorly differentiated ()
3 Male 43 Antrum 85 mm () 53 1 Poorly differentiated ()
4 Female 57 Antrum 74 mm () 61 2 Signet ring cell ()
er o
Lee et al Medicine  Volume 95, Number 14, April 2016performed to definitively establish the safety and feasibility of
ESD in superficial spreading EGC.
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